Graphite Bio
is a California-based biotechnology company that develops gene-based medicines for the treatment of serious genetic disorders... Read moreGraphite Bio
is a California-based biotechnology company that develops gene-based medicines for the treatment of serious genetic disorders... Read more
2017
PublicMerged with LENZ Therapeutics, Inc.NASDAQLENZ
News
Mar 25, 2024
VisionMonday
Graphite Bio: Lenz Therapeutics Completes Merger With Graphite Bio, Inc.
Mar 22, 2024
MarketScreener
Graphite Bio: Graphite Bio : Report of Independent Registered Public Accounting Firm - Form 8-K
Feb 27, 2024
Marketscreener
Graphite Bio: Graphite Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Jan 27, 2024
centralcharts
Press Release: Graphite Bio : GRAPHITE BIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH
Dec 08, 2023
Endpoints News
Graphite Bio: Graphite Bio divests gene editing pipeline to newly-formed Kamau Therapeutics after announcing reverse merger with Lenz Therapeutics
Nov 17, 2023
Acrofan
Graphite Bio: GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH
Nov 17, 2023
Americanbankingnews
Graphite Bio: Graphite Bio, Inc. (NASDAQ:GRPH) to Post Q4 2023 Earnings of ($0.16) Per Share, Leerink Partnrs Forecasts
Nov 16, 2023
Eyewire News
Graphite Bio: LENZ Therapeutics and Graphite Bio Announce Merger
Nov 13, 2023
Marketscreener
Graphite Bio: Graphite Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Aug 14, 2023
Marketscreener
Graphite Bio: Graphite Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Graphite Bio Competitors
1
2
3
4
5
6
7
8
9
10